Citadel Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,957,423
Closed -$6.17M 5944
2020
Q3
$6.17M Sell
1,957,423
-535,909
-21% -$1.69M ﹤0.01% 1378
2020
Q2
$7.26M Sell
2,493,332
-690,346
-22% -$2.01M ﹤0.01% 1268
2020
Q1
$8.98M Buy
3,183,678
+182,542
+6% +$515K ﹤0.01% 1064
2019
Q4
$9.74M Buy
3,001,136
+852
+0% +$2.77K ﹤0.01% 1185
2019
Q3
$6.48M Sell
3,000,284
-7,268
-0.2% -$15.7K ﹤0.01% 1474
2019
Q2
$9.44M Buy
3,007,552
+500,817
+20% +$1.57M ﹤0.01% 1226
2019
Q1
$9.33M Sell
2,506,735
-1,734,895
-41% -$6.45M ﹤0.01% 1171
2018
Q4
$12.3M Sell
4,241,630
-157,181
-4% -$456K 0.01% 900
2018
Q3
$11.6M Buy
4,398,811
+850,624
+24% +$2.24M 0.01% 1028
2018
Q2
$8.3M Buy
3,548,187
+1,948,181
+122% +$4.56M ﹤0.01% 1114
2018
Q1
$4.7M Buy
+1,600,006
New +$4.7M ﹤0.01% 1323
2017
Q4
Sell
-219,860
Closed -$745K 4600
2017
Q3
$745K Sell
219,860
-3,439,309
-94% -$11.7M ﹤0.01% 2468
2017
Q2
$9.04M Sell
3,659,169
-1,810,803
-33% -$4.47M 0.01% 910
2017
Q1
$12.4M Buy
5,469,972
+2,445,606
+81% +$5.55M 0.01% 794
2016
Q4
$6.41M Buy
3,024,366
+2,956,484
+4,355% +$6.27M 0.01% 927
2016
Q3
$228K Buy
67,882
+15,654
+30% +$52.6K ﹤0.01% 2991
2016
Q2
$164K Buy
52,228
+30,514
+141% +$95.8K ﹤0.01% 2868
2016
Q1
$72K Sell
21,714
-537,090
-96% -$1.78M ﹤0.01% 2954
2015
Q4
$1.98M Buy
558,804
+271,584
+95% +$961K ﹤0.01% 1578
2015
Q3
$1.45M Buy
287,220
+285,098
+13,435% +$1.43M ﹤0.01% 1947
2015
Q2
$14K Sell
2,122
-571,539
-100% -$3.77M ﹤0.01% 3669
2015
Q1
$4.04M Buy
573,661
+453,210
+376% +$3.19M ﹤0.01% 1388
2014
Q4
$928K Buy
120,451
+51,804
+75% +$399K ﹤0.01% 2158
2014
Q3
$513K Buy
68,647
+56,668
+473% +$423K ﹤0.01% 2423
2014
Q2
$116K Sell
11,979
-95,282
-89% -$923K ﹤0.01% 2965
2014
Q1
$892K Sell
107,261
-944,390
-90% -$7.85M ﹤0.01% 1922
2013
Q4
$8.88M Buy
1,051,651
+42,710
+4% +$360K 0.01% 812
2013
Q3
$8.04M Sell
1,008,941
-114,865
-10% -$915K 0.01% 793
2013
Q2
$8.68M Buy
+1,123,806
New +$8.68M 0.01% 784